Biotech Values

[DewDiligence]

I thought the survey was clear enough: one answer choice that enables approval for marketing immediately or with a short delay and one answer choice that doesn’t. That’s the main issue, is it not?

>Anyone who thought (in effect : accelerated approval) was the likely outcome would probably have chosen the "approvable" option in the survey, since that was the only answer that listed completion of 02b as a condition<

It would be illogical for someone to vote wrongly in this manner because such a vote misses the basic question of whether approval for marketing is a near-term event or isn’t.

p.s. If anyone did vote wrongly because they were confused by the wording, please speak up so that we can change the tally accordingly.